l.solberg

TL2 Moderator · Medellín

Contributes reviews on supplier material. Based in Medellín.

Joined 6 April 2025 · last posted 4d

80 posts, newest first. Showing up to 150.

Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #93 · Practice › Dosing & titration · 24 Jul 2026 · 26 likes Worth separating two things that post #89 runs together. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #34 · Access › Insurance & coverage · 16 Jul 2026 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Common supplements people ask about, assessed one at a time Replied, post #54 · Practice › Interactions · 16 Jul 2026 · 4 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
What I would want from a home test that does not exist yet Replied, post #37 · Analytics › Home & field testing · 14 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #36 · Evidence › Journal club · 8 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Journal club: what we got wrong in an earlier session Replied, post #61 · Evidence › Journal club · 7 Jul 2026 · 11 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #93 · Safety › Contraindications · 30 Jun 2026 · 25 likes Severe renal impairment (eGFR
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #67 · Compounds › Semaglutide · 17 Jun 2026 · 0 likes post #66 is right about the mechanism and I think understates the practical bit. The SELECT trial changed the positioning because it was the first cardiovascular…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #35 · Analytics › Home & field testing · 15 Jun 2026 · 10 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #111 · Practice › Storage & stability · 9 Jun 2026 · 24 likes This follows post #108 rather than contradicting it. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know…
Pooling trials with different estimands Replied, post #9 · Evidence › Meta-analyses · 6 Jun 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #114 · Compounds › Tirzepatide · 1 Jun 2026 · 13 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Gastro-oesophageal reflux: improving or worsening? Replied, post #50 · Clinical › Comorbidities · 29 May 2026 · 4 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Reconstitution volumes that produce round numbers, tabulated Replied, post #112 · Practice › Reconstitution · 10 May 2026 · 0 likes post #111 answers the question as asked. The question underneath it is different. Choosing a concentration on purpose rather than by accident: starting with "I want to…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #4 · Analytics › Impurities & related substances · 9 May 2026 · 26 likes This follows post #2 rather than contradicting it. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated.…
Why this community will not facilitate a group purchase Replied, post #3 · Sourcing › Payments · 30 Apr 2026 · 5 likes post #2 is right about the mechanism and I think understates the practical bit. Cryptocurrency for payment: offers less fraud protection than credit cards and is final…
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #6 · Documentation › Doc review · 29 Apr 2026 · 6 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
Follow-up: Sleep quality changes during weight loss Replied, post #11 · Wellbeing › Sleep · 26 Apr 2026 · 22 likes On post #7 — agreed on the reasoning, with one qualification. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #50 · Practice › Administration · 26 Apr 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
How to ask about something you suspect is a bad idea Replied, post #80 · Start Here › How to Ask · 23 Apr 2026 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #32 · Evidence › Journal club · 18 Apr 2026 · 11 likes Worth separating two things that post #28 runs together. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #35 · Devices › Syringes & needles · 16 Apr 2026 · 4 likes I read post #33 twice before replying, because I had assumed the opposite. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
Follow-up: State-level differences that actually matter Replied, post #83 · Regional › North America · 8 Apr 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #30 · Evidence › Journal club · 3 Apr 2026 · 6 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Choosing which test to pay for, given a fixed budget Replied, post #48 · Sourcing › Independent verification · 31 Mar 2026 · 0 likes On post #44 — agreed on the reasoning, with one qualification. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest…
A site rotation scheme that is easy enough to actually follow Replied, post #26 · Practice › Administration · 24 Mar 2026 · 13 likes Worth separating two things that post #22 runs together. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary…
Grapefruit: why this class is not the class that cares Replied, post #43 · Practice › Interactions · 15 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #120 · Practice › Interactions · 26 Feb 2026 · 27 likes Coming back to post #118, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #94 · Access › Pricing · 20 Feb 2026 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
MHRA statements, read directly Replied, post #86 · Regional › UK & Ireland · 10 Feb 2026 · 13 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
Reading an interaction checker output critically Replied, post #105 · Practice › Interactions · 29 Jan 2026 · 0 likes Coming back to post #103, because the follow-up matters more than the original answer. Supplements and herbs: many have no established interaction. Some do. If you are…
Managing an unplanned gap in supply Started this topic · Access › Shortages · 4 Jan 2026 · 0 likes Managing an unplanned gap in supply — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since…
Prescription requirements and telehealth models Replied, post #79 · Sourcing › Regulatory · 20 Dec 2025 · 0 likes This follows post #76 rather than contradicting it. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #72 · Practice › Interactions · 19 Dec 2025 · 17 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
Cost per delivered dose, which is the number that matters Replied, post #31 · Access › Pricing · 18 Dec 2025 · 0 likes post #30 answers the question as asked. The question underneath it is different. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #43 · Compounds › Semaglutide · 10 Dec 2025 · 16 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Publishing an inconvenient result: a case study — the long version Replied, post #51 · Sourcing › Independent verification · 27 Nov 2025 · 12 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #2 · Analytics › COA interpretation · 20 Nov 2025 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #22 · Pharmacology › Pharmacokinetics · 19 Nov 2025 · 2 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #36 · Sourcing › Regulatory · 18 Nov 2025 · 2 likes post #35 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Amylin receptor signalling and satiety Replied, post #22 · Pharmacology › Receptor biology · 31 Oct 2025 · 8 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
Can a home kit substitute for a laboratory report? A careful no Replied, post #42 · Analytics › Home & field testing · 30 Oct 2025 · 0 likes Coming back to post #40, because the follow-up matters more than the original answer. False positives and false negatives: no test has 100% sensitivity and 100%…
What a purity-only report leaves out Replied, post #51 · Sourcing › Independent verification · 18 Oct 2025 · 1 like I read post #49 twice before replying, because I had assumed the opposite. When results are inconclusive: if a testing service reports "insufficient to verify" on a…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #68 · Practice › Reconstitution · 14 Oct 2025 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
Journal club: STEP 3 and the intensive behavioural therapy floor Started this topic · Evidence › Journal club · 11 Oct 2025 · 38 likes Posting this under the heading it deserves: Journal club: STEP 3 and the intensive behavioural therapy floor Everything below is what sits behind that. Comparing SCALE…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #142 · Data & Tools › Calculators · 7 Oct 2025 · 0 likes Coming back to post #140, because the follow-up matters more than the original answer. Reporting bugs: if you notice a calculator giving wrong results, report it in…
Publishing an inconvenient result: a case study — the long version Replied, post #2 · Sourcing › Independent verification · 2 Oct 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #40 · Pharmacology › Receptor biology · 16 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #101 · Access › Insurance & coverage · 31 Aug 2025 · 12 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
Reporting a disappointing outcome, and why it belongs here Replied, post #25 · Outcomes › Progress reports · 20 Aug 2025 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #8 · Analytics › HPLC & UHPLC · 14 Jul 2025 · 1 like Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
Journal club: how we handle discontinuation in obesity trials Started this topic · Evidence › Journal club · 30 Jun 2025 · 15 likes On the subject in the title: Journal club: how we handle discontinuation in obesity trials Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J…
[2026 update] An appeal that failed, and what I would do differently Replied, post #74 · Access › Insurance & coverage · 12 Jun 2025 · 1 like This follows post #71 rather than contradicting it. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #49 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 1 like Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #25 · Evidence › Journal club · 3 Jun 2025 · 5 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Half-life, steady state, and accumulation worked through Replied, post #47 · Pharmacology › Pharmacokinetics · 31 May 2025 · 15 likes Worth separating two things that post #43 runs together. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises…
Pregnancy as an absolute contraindication Replied, post #96 · Safety › Contraindications · 20 May 2025 · 0 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
Second pass at: Designing a personal experiment that could change your mind Replied, post #31 · Research Methods › N-of-1 designs · 20 May 2025 · 16 likes Picking up post #28: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
DXA precision and the least significant change for lean mass — the long version Replied, post #54 · Outcomes › Body composition · 17 May 2025 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #150 · Sourcing › Regulatory · 12 May 2025 · 0 likes post #149 is right about the mechanism and I think understates the practical bit. Primary documents matter: regulatory positions are published in official documents.…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #53 · Sourcing › Independent verification · 5 May 2025 · 7 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
Follow-up: Documentation that appears only after payment Replied, post #22 · Sourcing › Red flags · 25 Apr 2025 · 27 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #92 · Evidence › Journal club · 21 Apr 2025 · 12 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #73 · Evidence › Journal club · 20 Apr 2025 · 14 likes Worth separating two things that post #69 runs together. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in…
Units, standards, and other things that quietly hold the world together Replied, post #18 · Lounge › Off topic · 13 Apr 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Follow-up: What other technical communities get right that we do not Replied, post #64 · Lounge › Off topic · 11 Apr 2025 · 25 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #46 · Practice › Reconstitution · 8 Apr 2025 · 0 likes Worth separating two things that post #42 runs together. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They…
Reporting a disappointing outcome, and why it belongs here Replied, post #6 · Outcomes › Progress reports · 5 Mar 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
SNAC and the mechanism of oral peptide absorption Replied, post #11 · Compounds › Oral incretins · 22 Feb 2025 · 0 likes Worth separating two things that post #7 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #3 · Practice › Dosing & titration · 8 Jan 2025 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Building a sensible monitoring schedule with your prescriber Replied, post #40 · Clinical › Bloodwork · 20 Dec 2024 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #3 · marked as the solution · Compounds › Semaglutide · 17 Dec 2024 · 7 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #10 · Evidence › Journal club · 6 Dec 2024 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Time to steady state after a dose increase Replied, post #53 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino)…
When a red flag was a misunderstanding, and the retraction Replied, post #37 · Sourcing › Red flags · 19 Oct 2024 · 0 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Second pass at: When a network meta-analysis is defensible and when it is not Started this topic · Evidence › Meta-analyses · 3 Oct 2024 · 2 likes Posting this under the heading it deserves: Second pass at: When a network meta-analysis is defensible and when it is not Everything below is what sits behind that.…
Identical chromatograms across two different lots Replied, post #27 · Sourcing › Red flags · 19 Sep 2024 · 9 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
Blind submission and why it changes minds Replied, post #61 · Sourcing › Independent verification · 14 Sep 2024 · 3 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Circumference measurements as a poor man's composition estimate Replied, post #39 · Outcomes › Body composition · 3 Aug 2024 · 3 likes On post #35 — agreed on the reasoning, with one qualification. Maintenance phase: tracking body composition during maintenance (weight stable) is different from…
Cold packs, phase-change material, and what survives ten days Replied, post #104 · Sourcing › Logistics · 14 Jul 2024 · 10 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…